- Home
- QTRX vs RLTY Comparison
QTRX vs RLTY Comparison
Compare QTRX & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- RLTY
- Stock Information
- Founded
- QTRX 2007
- RLTY 2022
- Country
- QTRX United States
- RLTY United States
- Employees
- QTRX N/A
- RLTY N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- RLTY Investment Managers
- Sector
- QTRX Industrials
- RLTY Finance
- Exchange
- QTRX Nasdaq
- RLTY Nasdaq
- Market Cap
- QTRX 233.5M
- RLTY 255.5M
- IPO Year
- QTRX 2017
- RLTY N/A
- Fundamental
- Price
- QTRX $5.85
- RLTY $15.43
- Analyst Decision
- QTRX Buy
- RLTY
- Analyst Count
- QTRX 4
- RLTY 0
- Target Price
- QTRX $13.50
- RLTY N/A
- AVG Volume (30 Days)
- QTRX 691.9K
- RLTY 86.7K
- Earning Date
- QTRX 08-07-2025
- RLTY 01-01-0001
- Dividend Yield
- QTRX N/A
- RLTY 9.35%
- EPS Growth
- QTRX N/A
- RLTY N/A
- EPS
- QTRX N/A
- RLTY N/A
- Revenue
- QTRX $135,688,000.00
- RLTY N/A
- Revenue This Year
- QTRX N/A
- RLTY N/A
- Revenue Next Year
- QTRX $14.28
- RLTY N/A
- P/E Ratio
- QTRX N/A
- RLTY N/A
- Revenue Growth
- QTRX 7.71
- RLTY N/A
- 52 Week Low
- QTRX $4.05
- RLTY $11.38
- 52 Week High
- QTRX $16.01
- RLTY $14.60
- Technical
- Relative Strength Index (RSI)
- QTRX 50.18
- RLTY 54.81
- Support Level
- QTRX $5.09
- RLTY $15.09
- Resistance Level
- QTRX $5.84
- RLTY $15.42
- Average True Range (ATR)
- QTRX 0.38
- RLTY 0.20
- MACD
- QTRX -0.05
- RLTY 0.00
- Stochastic Oscillator
- QTRX 48.41
- RLTY 65.69
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.